{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:01:23Z","timestamp":1789203683183,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.amjopharm.2009.11.001","type":"journal-article","created":{"date-parts":[[2009,11,28]],"date-time":"2009-11-28T09:36:41Z","timestamp":1259401001000},"page":"250-261","source":"Crossref","is-referenced-by-count":103,"title":["Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review"],"prefix":"10.1016","volume":"7","author":[{"given":"Kairav","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah U.","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Kunik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2009.11.001_bib1","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: A Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.amjopharm.2009.11.001_bib2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1525-1497.2001.10123.x","article-title":"National estimates of the quantity and cost of informal caregiving for the elderly with dementia","volume":"16","author":"Langa","year":"2001","journal-title":"J Gen Intern Med."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000149585","article-title":"Early-onset dementia is associated with higher mortality","volume":"26","author":"Koedam","year":"2008","journal-title":"Dement Geriatr Cogn Disord."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib4","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S1474-4422(08)70169-8","article-title":"Alzheimer's disease and vascular dementia in developing countries: Prevalence, management, and risk factors [published correction appears in Lancet Neurol. 2008;7:867]","volume":"7","author":"Kalaria","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib5","first-page":"129","article-title":"Dementia drug development: Use of information systems to harmonize global drug development","volume":"33","author":"Whitehouse","year":"1997","journal-title":"Psychopharmacol Bull."},{"issue":"Suppl 1","key":"10.1016\/j.amjopharm.2009.11.001_bib6","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00019442-199821001-00002","article-title":"Epidemiology of dementia and Alzheimer's disease","volume":"6","author":"Hendrie","year":"1998","journal-title":"Am J Geriatr Psychiatry."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib7","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1001\/jama.1995.03530230032026","article-title":"The association between midlife blood pressure levels and late-life cognitive function","volume":"274","author":"Launer","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2009.11.001_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/oxfordjournals.aje.a116868","article-title":"Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study","volume":"138","author":"Elias","year":"1993","journal-title":"Am J Epidemiol."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib9","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","article-title":"15-Year longitudinal study of blood pressure and dementia","volume":"347","author":"Skoog","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.amjopharm.2009.11.001_bib10","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/01.HYP.31.3.780","article-title":"Hypertension is related to cognitive impairment: A 20-year follow-up of 999 men","volume":"31","author":"Kilander","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.amjopharm.2009.11.001_bib11","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1212\/WNL.58.8.1175","article-title":"The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function","volume":"58","author":"Posner","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.amjopharm.2009.11.001_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-3-7091-7508-8_19","article-title":"Aging, dementia and calcium metabolism","volume":"54","author":"Kanowski","year":"1998","journal-title":"J Neural Transm Suppl."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib13","first-page":"641","article-title":"Altered calcium homeostasis in brain aging and senile dementia, new approach to treat Alzheimer's disease [in Chinese]","volume":"28","author":"Zhang","year":"1993","journal-title":"Yao Xue Xue Bao."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1749-6632.1994.tb44422.x","article-title":"Increased hippocampal Ca2+ channel activity in brain aging and dementia. Hormonal and pharmacologic modulation","volume":"747","author":"Landfield","year":"1994","journal-title":"Ann NY Acad Sci."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib15","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2741\/2839","article-title":"The renin-angiotensin system, hypertension and cognitive dysfunc- tion in Alzheimer's disease: New therapeutic potential","volume":"13","author":"Takeda","year":"2008","journal-title":"Front Biosci."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1474-4422(07)70077-7","article-title":"Is inhibition of the reninangiotensin system a new treatment option for Alzheimer's disease?","volume":"6","author":"Kehoe","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1567205052772740","article-title":"The role of the brain renin-angiotensin system in neurodegenerative disorders","volume":"2","author":"Savaskan","year":"2005","journal-title":"Curr Alzheimer Res."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib19","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1212\/01.WNL.0000140705.23869.E9","article-title":"Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression","volume":"63","author":"Ohrui","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.amjopharm.2009.11.001_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2004.03.009","article-title":"Calcium channel blockers and risk of AD: The Baltimore Longitudinal Study of Aging","volume":"26","author":"Yasar","year":"2005","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/gerona\/60.1.67","article-title":"Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population","volume":"60","author":"Hajjar","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib22","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archneur.63.5.noc60013","article-title":"Antihypertensive medication use and incident Alzheimer disease: The Cache County Study","volume":"63","author":"Khachaturian","year":"2006","journal-title":"Arch Neurol."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib23","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archinte.166.9.1003","article-title":"Heart failure and risk of dementia and Alzheimer disease: A populationbased cohort study","volume":"166","author":"Qiu","year":"2006","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib24","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1097\/01.hjh.0000244961.69985.05","article-title":"Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints","volume":"24","author":"Hanon","year":"2006","journal-title":"J Hypertens."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib25","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease","volume":"163","author":"Tzourio","year":"2003","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/01.STR.0000155686.73908.3e","article-title":"Efficacy and safety of nimodipine in subcortical vascular dementia: A randomized placebo-controlled trial","volume":"36","author":"Pantoni","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.amjopharm.2009.11.001_bib27","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archneur.56.8.991","article-title":"Occurrence and progression of dementia in a community population aged 75 years and older: Relationship of antihypertensive medication use","volume":"56","author":"Guo","year":"1999","journal-title":"Arch Neurol."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib28","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The prevention of dementia with antihypertensive treatment: New evidence from the Systolic Hypertension in Europe (Syst-Eur) study [published correction appears in Arch Intern Med. 2003;163:241]","volume":"162","author":"Forette","year":"2002","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib29","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.amjhyper.2005.02.013","article-title":"Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)","volume":"18","author":"Skoog","year":"2005","journal-title":"Am J Hypertens."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): A doubleblind, placebo controlled trial","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.amjopharm.2009.11.001_bib31","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.amjopharm.2009.11.001_bib32","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)","volume":"265","year":"1991","journal-title":"JAMA"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594609000701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594609000701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T23:57:52Z","timestamp":1544831872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594609000701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1543594609000701"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2009.11.001","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}